[Indications for cytostatic treatment of patients with osteomyelosclerosis of osteomyelofibrosis].
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D002066:Busulfan / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008353:Mannitol / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D008875:Middle Aged; D010026:Osteosclerosis / Q000188:drug therapy*; D055728:Primary Myelofibrosis / Q000188:drug therapy*
D000970:Antineoplastic Agents; D008353:Mannitol; D015122:Mercaptopurine; D002066:Busulfan; D001379:Azathioprine
Indikationen zur zytostatischen Behandlung von Patienten mit Osteomyelosklerose bzw.-fibrose.